Epigenetics in Autoimmune Disorders: Highlights of the 10th Sjögren's Syndrome Symposium

Overview

Journal Autoimmun Rev

Publisher Elsevier

Specialty Allergy & Immunology

Date 2010 May 11

PMID 20452464

Citations 19

Authors

Qianjin Lu

Yves Renaudineau

Seunghee Cha

Gabor Ilei

Wesley H Brooks

Carlo Selmi

Athanasios Tzioufas

Jacques-Olivier Pers

Stefano Bombardieri

M Eric Gershwin

Steffen Gay

Pierre Youinou

Affiliations

Soon will be listed here.

Abstract

During the 10th International Symposium on Sjögren's Syndrome held in Brest, France, from October 1-3, 2009 (http://www.sjogrensymposium-brest2009.org), the creation of an international epigenetic autoimmune group has been proposed to establish gold standards and to launch collaborative studies. During this "epigenetics session", leading experts in the field presented and discussed the most recent developments of this topic in Sjögren's Syndrome research. The "Brest epigenetic task force" was born and has scheduled a meeting in Ljubljana, Slovenia during the 7th Autoimmunity congress in May 2010.The following is a report of that session.

Citing Articles

The new era of immune skin diseases: Exploring advances in basic research and clinical translations.

Zhang B, Mei X, Zhao M, Lu Q J Transl Autoimmun. 2024; 8:100232.

PMID: 39022635 PMC: 11252396. DOI: 10.1016/j.jtauto.2024.100232.

Decreased SUV39H1 at the promoter region leads to increased CREMα and accelerates autoimmune response in CD4 T cells from patients with systemic lupus erythematosus.

Luo S, Zhang H, Xie Y, Huang J, Luo D, Zhang Q Clin Epigenetics. 2022; 14(1):181.

PMID: 36536372 PMC: 9764740. DOI: 10.1186/s13148-022-01411-7.

Decreased Jumonji Domain-Containing 3 at the Promoter Downregulates Hematopoietic Progenitor Kinase 1 Expression and Cytoactivity of T Follicular Helper Cells from Systemic Lupus Erythematosus Patients.

Luo S, Xie Y, Huang J, Liu J, Zhang Q J Immunol Res. 2022; 2022:3690892.

PMID: 36213329 PMC: 9534702. DOI: 10.1155/2022/3690892.

Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren's Syndrome and Primary Biliary Cholangitis.

Arvaniti P, Zachou K, Lyberopoulou A, Gatselis N, Brooks W, Dalekos G Epigenomes. 2021; 3(3).

PMID: 34968227 PMC: 8594719. DOI: 10.3390/epigenomes3030015.

JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren's Syndrome.

Charras A, Arvaniti P, Le Dantec C, Arleevskaya M, Zachou K, Dalekos G Clin Rev Allergy Immunol. 2019; 58(2):182-193.

PMID: 31165348 DOI: 10.1007/s12016-019-08743-y.